» Articles » PMID: 11992261

PTPN11 Mutations in Noonan Syndrome: Molecular Spectrum, Genotype-phenotype Correlation, and Phenotypic Heterogeneity

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2002 May 7
PMID 11992261
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Noonan syndrome (NS) is a developmental disorder characterized by facial dysmorphia, short stature, cardiac defects, and skeletal malformations. We recently demonstrated that mutations in PTPN11, the gene encoding the non-receptor-type protein tyrosine phosphatase SHP-2 (src homology region 2-domain phosphatase-2), cause NS, accounting for approximately 50% of cases of this genetically heterogeneous disorder in a small cohort. All mutations were missense changes and clustered at the interacting portions of the amino-terminal src-homology 2 (N-SH2) and protein tyrosine phosphatase (PTP) domains. A gain of function was postulated as a mechanism for the disease. Here, we report the spectrum and distribution of PTPN11 mutations in a large, well-characterized cohort with NS. Mutations were found in 54 of 119 (45%) unrelated individuals with sporadic or familial NS. There was a significantly higher prevalence of mutations among familial cases than among sporadic ones. All defects were missense, and several were recurrent. The vast majority of mutations altered amino acid residues located in or around the interacting surfaces of the N-SH2 and PTP domains, but defects also affected residues in the C-SH2 domain, as well as in the peptide linking the N-SH2 and C-SH2 domains. Genotype-phenotype analysis revealed that pulmonic stenosis was more prevalent among the group of subjects with NS who had PTPN11 mutations than it was in the group without them (70.6% vs. 46.2%; P<.01), whereas hypertrophic cardiomyopathy was less prevalent among those with PTPN11 mutations (5.9% vs. 26.2%; P<.005). The prevalence of other congenital heart malformations, short stature, pectus deformity, cryptorchidism, and developmental delay did not differ between the two groups. A PTPN11 mutation was identified in a family inheriting Noonan-like/multiple giant-cell lesion syndrome, extending the phenotypic range of disease associated with this gene.

Citing Articles

Optimized phenotyping of complex morphological traits: enhancing discovery of common and rare genetic variants.

Yuan M, Goovaerts S, Lee M, Devine J, Richmond S, Walsh S Brief Bioinform. 2025; 26(2).

PMID: 40062617 PMC: 11891655. DOI: 10.1093/bib/bbaf090.


Genomic signatures of adaptation in native lizards exposed to human-introduced fire ants.

Assis B, Sullivan A, Marciniak S, Bergey C, Garcia V, Szpiech Z Nat Commun. 2025; 16(1):89.

PMID: 39746982 PMC: 11695932. DOI: 10.1038/s41467-024-55020-4.


Variants of the Gene in Mexican Patients with Noonan Syndrome.

Zepeda-Olmos P, Esparza-Garcia E, Robles-Espinoza K, Gonzalez-Garcia J, Rodriguez Gutierrez P, Magana-Torres M Genes (Basel). 2024; 15(11).

PMID: 39596579 PMC: 11593480. DOI: 10.3390/genes15111379.


Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome.

Staunton J, Ajuyah P, Harris A, Mayoh C, Wong M, Rumford M NPJ Precis Oncol. 2024; 8(1):236.

PMID: 39427038 PMC: 11490609. DOI: 10.1038/s41698-024-00734-3.


An Unexpected Finding of a PTPN11 Germline Mutation in a Patient With a Melanocytic Lesion With a Somatic MAP2K1 Mutation. Coincidence or Not?.

van der Woude S, Klein Wassink-Ruiter J, Kluiver J, de Jonge M, Diercks G J Cutan Pathol. 2024; 52(1):20-23.

PMID: 39392019 PMC: 11652124. DOI: 10.1111/cup.14730.


References
1.
NORA J, Nora A, Sinha A, Spangler R, Lubs H . The Ullrich-Noonan syndrome (Turner phenotype). Am J Dis Child. 1974; 127(1):48-55. DOI: 10.1001/archpedi.1974.02110200050007. View

2.
Marino B, Digilio M, Toscano A, Giannotti A, Dallapiccola B . Congenital heart diseases in children with Noonan syndrome: An expanded cardiac spectrum with high prevalence of atrioventricular canal. J Pediatr. 1999; 135(6):703-6. DOI: 10.1016/s0022-3476(99)70088-0. View

3.
Allanson J . Noonan syndrome. J Med Genet. 1987; 24(1):9-13. PMC: 1049850. DOI: 10.1136/jmg.24.1.9. View

4.
Cohen Jr M, GORLIN R . Noonan-like/multiple giant cell lesion syndrome. Am J Med Genet. 1991; 40(2):159-66. DOI: 10.1002/ajmg.1320400208. View

5.
Tsui H, Siminovitch K, de Souza L, Tsui F . Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet. 1993; 4(2):124-9. DOI: 10.1038/ng0693-124. View